Loading company…
Omeza develops wound care products for chronic wounds and serious skin conditions.
Founded in 2014 and based in Sarasota, US, Omeza develops advanced wound care products for patients with chronic wounds and serious skin conditions. Its OCM wound matrix is a drug-device combination intended to support wound healing. In April 2026, the company raised USD 8.5 mn with participation from Astanor Ventures, BluKap, Catalyst Investments, and Florida Opportunity Fund to support clinical trials and commercial growth.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in